Akebia Therapeutics, Inc.
2019 Q4 - 2025 Q4 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 400 | 0.0% | 248,204 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 676 | 0.0% | 247,700 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 55 | 0.0% | 15,073 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 29 | 0.0% | 15,073 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 29 | 0.0% | 15,073 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 20 | 0.0% | 15,073 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 15 | 0.0% | 15,073 | 6/30/2024 |
| 2022 Q1 | 5/16/2022 | 155 | 0.0% | 215,881 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 532 | 0.0% | 235,405 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 623 | 0.0% | 216,225 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 835 | 0.0% | 220,205 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 731 | 0.0% | 215,960 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 607 | 0.0% | 216,794 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 544 | 0.0% | 216,794 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 2,665 | 0.0% | 196,268 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 1,352 | 0.0% | 178,308 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,140 | 0.0% | 180,320 | 12/31/2019 |